Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study
- PMID: 24507585
- PMCID: PMC3996139
- DOI: 10.1186/1756-0500-7-86
Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study
Abstract
Background: No previous studies have examined the effect of intensive exercise in systemic sclerosis patients with pulmonary impairment. The objective of this study was to examine the effect of an eight-week intensive aerobic exercise and muscle endurance training program for patients with systemic sclerosis with 50-100% of forced vital capacity.
Methods: A single-subject experimental design with repeated systematic measures during a six week A-phase (non-interventional baseline period) and an eight week B-phase (exercise intervention period) was used. Three women and one man with median age 66 years and median disease duration of 3.5 years completed aerobic exercise corresponding to 15 on the Borg RPE scale (strenuous) and muscular endurance training three times/week. Physical capacity (six-minute walk test), aerobic capacity (submaximal treadmill test) and muscle endurance in shoulder and hip flexion (Functional Index 2) were assessed every other week throughout the 14-week study. Activity limitation (Health Assessment Questionnaire), quality of life (Short Form 36), Raynaud, Fatigue and Global Health during the recent week (Visual Analogue Scales) were assessed at weeks 0, 6, 14.
Results: Three participants improved significantly in muscular endurance, and two participants improved significantly or clinically relevant in aerobic capacity. All other variables remained unchanged, except for a trend towards reduced fatigue.
Conclusions: This eight week exercise program was largely successful with positive effects on aerobic capacity and muscle endurance.
Trial registration: Clinicaltrials.gov Identifier: NCT01813578.
Figures
References
-
- Hinchcliff M, Varga J. Systemic sclerosis/Scleroderma: a treatable multisystem disease. Am Fam Physician. 2010;78:961–968. - PubMed
-
- Proudman SM, Stevens WM, Sahhar J, Celermajer D. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J. 2007;37:485.494. - PubMed
-
- Mouthon L, Berezné A, Brauner M, Kambouchner M, Guillevin L, Valeyre D. Interstitial lung disease in systemic sclerosis. Rev Mal Respir. 2007;24:1–11. - PubMed
-
- Avouac J, Walker U, Tyndall A, Kahan A, Matucci-Cerinic M, Allanore Y. et al.Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR scleroderma trial and research group (EUSTAR) database. J Rheumatol. 2010;37:1488–1501. doi: 10.3899/jrheum.091165. - DOI - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical